Herbal Supplement Recalled for Undeclared Viagra Ingredient
Primal Supplements Group urgently recalls its Primal Herbs Volume due to undeclared sildenafil, posing serious health risks like dangerous blood pressure drops when mixed with nitrates.
Category : Pharmaceuticals
Blood Pressure Drug Recall Issued Over Packaging Mistake
Patients on Ramipril 5mg capsules are warned to check batch GR164099 after a packaging error led to Amlodipine tablets being included instead.
Weight-Loss Drug Users Sue Over Blindness and Death Side Effects
Exclusive: Americans reveal devastating side effects from Ozempic and Wegovy, including permanent blindness and fatal vomiting episodes, as lawsuits mount against Novo Nordisk.
Tesco Recalls Blood Pressure Medication Over Packaging Mix-Up
Tesco Pharmacy has issued an urgent recall for a batch of Ramipril 5mg capsules mistakenly packed with Amlodipine tablets. Customers are warned to check batch codes and return affected products immediately.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Eli Lilly Warns of Impurity in Compounded Weight-Loss Drugs
Eli Lilly has issued a public health alert about a potentially dangerous impurity found in compounded versions of its weight-loss drug Zepbound. The company warns that the impurity, formed when tirzepatide mixes with vitamin B12, poses unknown risks to co
Ancient Resin Boswellia May Ease Arthritis, Asthma and Fight Cancer
Scientists are increasingly finding evidence that Boswellia serrata, an herbal extract used for centuries in Ayurvedic medicine, could help reduce inflammation, ease arthritis pain, improve asthma symptoms, and potentially slow cancer growth.
Ibuprofen and NSAIDs Linked to Higher Kidney Disease Risk, Experts Warn
Leading pharmacists and Kidney Care UK warn that common anti-inflammatory drugs like ibuprofen may raise the risk of deadly kidney disease, urging patients to monitor usage and consider alternatives.
Allulose: A Natural Sweetener Alternative to Ozempic for Weight Loss
As expensive GLP-1 drugs like Ozempic face side effect concerns, allulose, a low-calorie natural sweetener, is gaining attention for aiding weight loss, with one woman reporting a 74-pound drop in 10 months.
Mum Sues Pfizer Over Brain Tumours from Contraceptive Injection
Tammy Croston, 47, claims Depo-Provera injections caused four brain tumours and vision loss. She joins thousands suing Pfizer, but Scottish jurisdiction laws block her compensation fight.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Priest Warns Global Events May Herald Antichrist's Economic Rise
A Catholic priest has issued a stark warning that modern financial systems and digital technologies could create conditions for the Antichrist's emergence through economic control, as described in biblical prophecy.
Weight Loss Jabs Linked to Higher Eye Stroke Risk
A new study reveals weight-loss jab Wegovy may carry the highest risk of sudden sight loss, known as an eye stroke, compared to similar medications like Ozempic.
Wegovy Linked to Fivefold Higher Risk of Sudden Vision Loss
A study reveals Wegovy users face nearly five times the risk of sudden sight loss compared to Ozempic users, with 'eye strokes' potentially linked to semaglutide.
FDA Rejects $2.50 'Miracle Pill' for Autism Treatment
The FDA has declined to approve leucovorin, a $2.50 vitamin pill, for autism, despite earlier praise from officials. It was approved for cerebral folate deficiency, a condition linked to autism in many cases.
FDA Approves Leucovorin, Rejects Autism Claims
The FDA has approved leucovorin for a rare genetic brain condition while explicitly rejecting earlier White House suggestions it could treat autism. Prescriptions surged after Trump's comments.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
FDA Approves Generic Drug for Rare Disorder, Not Autism
The FDA has approved leucovorin for a rare genetic condition affecting folate delivery to the brain, but found little evidence to support its use for autism, contradicting earlier White House claims.
Superbug Drug Pipeline Thin, Deaths to Double by 2050
Experts warn the pipeline for new antibiotics has shrunk by 35%, with global deaths from drug-resistant infections forecast to hit 8 million annually by 2050. GSK leads research, but AstraZeneca is absent.
Urgent Recall of Ramipril Blood Pressure Medication
Crescent Pharma Limited recalls a batch of Ramipril 5 mg Capsules due to a manufacturing error that may have swapped them with Amlodipine tablets, prompting MHRA warnings about dizziness risks.
Novo Nordisk Drops Lawsuit, Partners with Hims & Hers
Novo Nordisk has dismissed its patent lawsuit against Hims & Hers and entered a collaboration to sell branded weight loss medications through the telehealth platform, sending Hims shares soaring over 40%.
Hims & Hers and Novo Nordisk Settle Lawsuit, Form Collaboration
Hims & Hers Health and Novo Nordisk have resolved their patent infringement lawsuit and entered a collaboration to sell branded weight-loss medications through the telehealth platform.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
UK Deaths Feared Linked to Weight-Loss Jabs Under Review
Two deaths in Northern Ireland, suspected to be tied to GLP-1 weight-loss medications like Mounjaro, have been reported to the MHRA. Over 500 adverse reaction reports from 2024-2025 highlight ongoing safety monitoring efforts.
Two Deaths Linked to Weight-Loss Jabs Reported to Regulator
The MHRA received reports of two deaths in Northern Ireland potentially connected to GLP-1 weight-loss medications, amid over 500 adverse reaction reports from 2024-2025.
UK Blood Pressure Drug Recall After Packaging Error
Crescent Pharma recalls Ramipril 5mg batch GR164099 after a patient found Amlodipine tablets inside. The MHRA urges pharmacies and patients to check packaging immediately.
Mounjaro KwikPen Redesign Ends 'Golden Dose' in UK
Eli Lilly's redesigned Mounjaro KwikPens will launch in the UK from April 2026, eliminating leftover medication that enabled a risky 'golden dose' practice amid price hikes.
Australian Dad Loses Access to Life-Saving Cancer Drug
Clinton James, a father-of-three battling rare medullary thyroid cancer, faces imminent death after losing subsidised access to Retevmo drug that was keeping him alive.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Zealand Pharma Shares Plunge 30% After Drug Trial Failure
Danish biotech firm Zealand Pharma saw its shares plummet over 30% after mid-stage trial results for obesity drug petrelintide lagged behind rival treatments from Eli Lilly.
Weight-Loss Jabs May Cost $3 Monthly, Aiding Global Access
New analysis reveals semaglutide, used in Wegovy and Ozempic, could be produced for $3 a month, potentially expanding treatment for obesity and diabetes in 160 countries as patents expire.
Family Pleads for NHS Approval of New Cancer Treatment
The family of Huw Jones, who died from bile duct cancer, is calling on NHS officials to approve zanidatamab, a treatment that offers hope for patients with this aggressive disease.
CVS Threatens Tennessee Pharmacy Exit Over PBM Bill
CVS Health warns it may close all 134 pharmacies in Tennessee if Senate Bill 2040 passes, impacting 1.5 million patients and 2,000 jobs, amid debates over PBM ownership conflicts.
Zorevunersen Cuts Seizures in Dravet Syndrome Kids in Trials
An experimental drug, zorevunersen, has shown up to 91% reduction in seizures for children with Dravet syndrome in early trials, offering hope for improved quality of life.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
FDA Warns Savannah Chrisley Over Misleading Drug Claims
Reality star Savannah Chrisley received an FDA warning letter about misleading claims on her GoodGirlRX website regarding compounded GLP-1 weight loss medications.
Page 7 of 25
